Furthermore, tectorigenin inhibits pulmonary fibrosis and airway inflammation by modulating the TGFβ1/Smad and TLR4/NFκB signaling pathways, highlighting its potential role in preventing the structural lung changes associated with chronic asthma [224]. Here, TGFB1 is linked to pulmonary fibrosis.